Armis Biopharma company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

armisbiopharma.com

Stage

Convertible Note | Alive

Total Raised

$17.61M

Last Raised

$5.27M | 6 mos ago

About Armis Biopharma

Armis Biopharma is a development-stage biopharmaceutical company focused on creating patented products that successfully kill most deadly pathogens blamed for the rising number of healthcare-associated infections worldwide. The Company's lead technology Veriox is a peracid/hydrogen peroxide-based non-systemic, non-resistant antimicrobial agent. Veriox features an undefeatable Mechanism of Action (M of A) effective against Gram+, Gram-, viral, fungal and chemical/biological warfare pathogens.

Armis Biopharma Headquarter Location

2950 East Harmony Suite 252

Fort Collins, Colorado, 80528,

United States

970-704-8503

ESPs containing Armis Biopharma

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Cybersecurity

Medical device security solutions help healthcare providers identify, manage, secure, and monitor the medical devices connected to their network.

Armis Biopharma named as Highflier among 10 other companies, including Medigate, Ordr, and CyberMDX.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Armis Biopharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Armis Biopharma is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

11,542 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health IT

7,900 items

Armis Biopharma Patents

Armis Biopharma has filed 13 patents.

The 3 most popular patent topics include:

  • Dentistry
  • Dicarboxylic acids
  • Epoxides
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/24/2018

3/29/2022

Clusters of differentiation, Immune system, Transcription factors, Cell biology, Disinfectants

Grant

Application Date

9/24/2018

Grant Date

3/29/2022

Title

Related Topics

Clusters of differentiation, Immune system, Transcription factors, Cell biology, Disinfectants

Status

Grant

Latest Armis Biopharma News

Funding Friday: Sierra Space raises $8.94M

Feb 18, 2022

Notable rounds this week: Sierra Space Corp., the Broomfield-based spinoff of Sierra Nevada Corp., launched an indefinite equity and options funding round that has raised $8.94 million so far. Fort Collins company Armis Biopharma Inc. raised $5.27 million through conversion of notes. Armis focuses on the creation and development of novel, targeted, antimicrobial therapies to treat drug-resistant infections. MHB AHV East Village Investments LLC, an entity associated with Loveland developer McWhinney Real Estate Services Inc., raised $17.5 million in equity. Meridia Acquisitions LLC, an entity affiliated with Loveland real estate investment firm Four Mile Capital, raised $8.41 million through selling membership interests in a limited liability company. Boulder venture capital firm Moxxie Ventures launched a new VC fund, MoMoxxie I LP. The $50 million fund has not raised any capital yet. Unless Partners, a Boulder investment firm specializing in artificial intelligence, robotics and advanced manufacturing, launched the indefinite fund Unless Ventures LP. It has raised $12.8 million so far. Boulder multi-family office Crestone Capital LLC released annual reports for two of its investment funds. Kenosha Municipal Opportunities Fund III LP raised $43.8 million over the past year, its first. CC Tiger Global LP raised $5.6 million this past year to bring its total to $45.1 million. Welcome to Funding Friday, BizWest’s roundup of companies in Northern Colorado and the Boulder Valley kicking off fundraisers. BizWest reports fundraisers by companies in Boulder, Broomfield, Larimer and Weld counties, as well as Brighton and Westminster through regulatory filings, press releases and other sources. Did we miss a company’s round? Email us at news@bizwest.com . Notable rounds this week: Sierra Space Corp., the Broomfield-based spinoff of Sierra Nevada Corp., launched an indefinite equity and options funding round that has raised $8.94 million so far. Fort Collins company Armis Biopharma Inc. raised $5.27 million through conversion of notes. Armis focuses on the creation and development of novel, targeted, antimicrobial therapies to treat drug-resistant infections. MHB AHV East Village Investments LLC, an entity associated with Loveland developer McWhinney Real Estate Services Inc., raised $17.5 million in equity. Meridia Acquisitions LLC, an entity affiliated with Loveland real estate investment firm Four Mile Capital, raised $8.41 million through selling membership interests in a limited liability company. Boulder venture capital firm Moxxie Ventures launched a new VC fund, MoMoxxie I LP. The $50 million fund has not raised any capital yet. Unless Partners, a Boulder investment firm specializing in artificial intelligence, robotics and advanced manufacturing, launched the indefinite fund Unless Ventures LP. It has raised $12.8 million so far. Boulder multi-family office Crestone Capital LLC released annual reports for two of its investment funds. Kenosha Municipal Opportunities Fund III LP raised $43.8 million over the past year, its first. CC Tiger Global LP raised $5.6 million this past year to bring its total to… This article has been intentionally blurred. You must purchase a subscription to view the rest of this content. Want to See More! ?

Armis Biopharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Armis Biopharma Rank

  • Where is Armis Biopharma's headquarters?

    Armis Biopharma's headquarters is located at 2950 East Harmony, Fort Collins.

  • What is Armis Biopharma's latest funding round?

    Armis Biopharma's latest funding round is Convertible Note.

  • How much did Armis Biopharma raise?

    Armis Biopharma raised a total of $17.61M.

  • Who are the investors of Armis Biopharma?

    Investors of Armis Biopharma include National Institutes of Health.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.